Benzgalantamine Gluconate
Benzgalantamine Gluconate is a galantamine prodrug being developed for the treatment of Alzheimer disease.
Detailed technical, regulatory, and supply information is available for commercial evaluation.
Technical Overview
Benzgalantamine Gluconate – CAS 1542321-58-3
CAS Number
1542321-58-3
Category
Alzheimer disease
Therapeutic Class
Cholinesterase inhibitor prodrug
Description
Benzgalantamine Gluconate is a galantamine prodrug being developed for the treatment of Alzheimer disease.
Applications
- Alzheimer disease
- Cognitive impairment
Handling & Supply Details
Packaging
Standard export packaging in double-lined HDPE drums or fiber drums with inner poly liners; custom pack sizes available on request.
Product Inquiry
Disclaimer
Products offered are intended strictly for R&D, registration and/or export purposes only. The responsibility for ensuring that the product does not infringe any third-party patent or intellectual property rights in the destination country rests solely with the buyer.